United States · Funded startup

Who invested in Arrogene

5 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$3.9Mraised across 5 rounds since 2010, from 5 sources

$727KVenture$2.3MVenture
Latest round
Debt, $250KJan 2015
Biggest round
$2.3MVenture · Jun 2013
Step-upi
1.5×
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20112012201320142015
$727KVenture$497KDebt$2.3MVenture$170KDebt$250KDebt
First round
Venture, $727K
Oct 2010
Biggest round
$2.3M
Venture · Jun 2013
Usual gap between rounds
10 months
the median of 4

The rounds

  1. Jan 2015
    Debt$250K

    No investor was named in the report.

    From a historical funding recordSEC filing: $250K sold, first sale Dec 2014

  2. Mar 2014
    Debt$170K

    No investor was named in the report.

    From a historical funding recordSEC filing: $170K sold, first sale Feb 2014

  3. Jun 2013
    Venture$2.3M

    No investor was named in the report.

    Reported by sec.govSEC filing: $2.3M sold, first sale Jan 2012

  4. Mar 2011
    Debt$497K

    No investor was named in the report.

    Reported by sec.gov

  5. Oct 2010
    Venture$727K

    No investor was named in the report.

    Reported by sec.gov

Quick answers about Arrogene

How much has Arrogene raised?

Arrogene has raised $3.9M across 5 rounds since 2010.

When did Arrogene last raise?

Arrogene's most recent round was a Debt of $250K in Jan 2015.

What was Arrogene's biggest round?

Arrogene's largest round on record is $2.3M (Venture), in Jun 2013.

What stage is Arrogene at?

Arrogene's latest named round is a Debt, in Jan 2015.

Where is Arrogene based?

Arrogene is based in the United States.

Companies like Arrogene

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.